These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32800880)

  • 21. Endemic and Epidemic Human Alphavirus Infections in Eastern Panama: An Analysis of Population-Based Cross-Sectional Surveys.
    Carrera JP; Cucunubá ZM; Neira K; Lambert B; Pittí Y; Liscano J; Garzón JL; Beltran D; Collado-Mariscal L; Saenz L; Sosa N; Rodriguez-Guzman LD; González P; Lescano AG; Pereyra-Elías R; Valderrama A; Weaver SC; Vittor AY; Armién B; Pascale JM; Donnelly CA
    Am J Trop Med Hyg; 2020 Dec; 103(6):2429-2437. PubMed ID: 33124532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotechnological Applications of an Insect-Specific Alphavirus.
    Erasmus JH; Weaver SC
    DNA Cell Biol; 2017 Dec; 36(12):1045-1049. PubMed ID: 29161110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Antibody Responses to Emerging Mayaro Virus and Cocirculating Alphavirus Infections Examined by Using Structural Proteins from Nine New and Old World Lineages.
    Smith JL; Pugh CL; Cisney ED; Keasey SL; Guevara C; Ampuero JS; Comach G; Gomez D; Ochoa-Diaz M; Hontz RD; Ulrich RG
    mSphere; 2018; 3(2):. PubMed ID: 29577083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection.
    Calvert AE; Bennett SL; Hunt AR; Fong RH; Doranz BJ; Roehrig JT; Blair CD
    Virology; 2022 Jan; 565():13-21. PubMed ID: 34626907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.
    Hunt AR; Frederickson S; Maruyama T; Roehrig JT; Blair CD
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e739. PubMed ID: 20644615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Humoral Immune Responses in Chikungunya Virus (CHIKV)-Infected Patients and Individuals Vaccinated With a Candidate CHIKV Vaccine.
    Henss L; Yue C; Von Rhein C; Tschismarov R; Lewis-Ximenez LL; Dölle A; Baylis SA; Schnierle BS
    J Infect Dis; 2020 Apr; 221(10):1713-1723. PubMed ID: 31828322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges.
    Dupuy LC; Richards MJ; Livingston BD; Hannaman D; Schmaljohn CS
    J Immunol Res; 2018; 2018():8521060. PubMed ID: 29967804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.
    Phillips AT; Schountz T; Toth AM; Rico AB; Jarvis DL; Powers AM; Olson KE
    J Virol; 2014 Feb; 88(3):1771-80. PubMed ID: 24257615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination.
    Perkins SD; O'Brien LM; Phillpotts RJ
    Vaccine; 2006 Apr; 24(17):3440-5. PubMed ID: 16527377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
    Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.
    Campos RK; Preciado-Llanes L; Azar SR; Kim YC; Brandon O; López-Camacho C; Reyes-Sandoval A; Rossi SL
    Front Immunol; 2020; 11():591885. PubMed ID: 33224148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.
    Kam YW; Lum FM; Teo TH; Lee WW; Simarmata D; Harjanto S; Chua CL; Chan YF; Wee JK; Chow A; Lin RT; Leo YS; Le Grand R; Sam IC; Tong JC; Roques P; Wiesmüller KH; Rénia L; Rötzschke O; Ng LF
    EMBO Mol Med; 2012 Apr; 4(4):330-43. PubMed ID: 22389221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies.
    Porta J; Jose J; Roehrig JT; Blair CD; Kuhn RJ; Rossmann MG
    J Virol; 2014 Sep; 88(17):9616-23. PubMed ID: 24920796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.
    Atasheva S; Kim DY; Frolova EI; Frolov I
    J Virol; 2015 Jan; 89(1):71-82. PubMed ID: 25320296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of mouse monoclonal antibodies targeting linear epitopes on Chikungunya virus E2 glycoprotein.
    Chua CL; Chan YF; Sam IC
    J Virol Methods; 2014 Jan; 195():126-33. PubMed ID: 24134938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of Escherichia coli expressed envelope 2 protein of Chikungunya virus.
    Tripathi NK; Priya R; Shrivastava A
    Bioengineered; 2014; 5(3):198-203. PubMed ID: 24637708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses.
    Malonis RJ; Earnest JT; Kim AS; Angeliadis M; Holtsberg FW; Aman MJ; Jangra RK; Chandran K; Daily JP; Diamond MS; Kielian M; Lai JR
    Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34507983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric alphavirus vaccine candidates for chikungunya.
    Wang E; Volkova E; Adams AP; Forrester N; Xiao SY; Frolov I; Weaver SC
    Vaccine; 2008 Sep; 26(39):5030-9. PubMed ID: 18692107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
    Rosas CT; Paessler S; Ni H; Osterrieder N
    Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.
    Kendra JA; de la Fuente C; Brahms A; Woodson C; Bell TM; Chen B; Khan YA; Jacobs JL; Kehn-Hall K; Dinman JD
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.